Literature DB >> 24630507

Non alcoholic fatty liver disease (NAFLD) in a Sudanese population: What is the prevalence and risk factors?

Ahmed O Almobarak1, Salma Barakat2, Mai H Khalifa1, Mohamed H Elhoweris3, Tayseer M Elhassan4, Mohamed H Ahmed5.   

Abstract

BACKGROUND AND STUDY AIMS: Non alcoholic fatty liver disease (NAFLD) is a common clinical condition associated with obesity and considered as possible precursor of more serious disease like Non alcoholic steatohepatitis (NASH), cirrhosis and hepatocellular carcinoma. There is very little research work carried concerning NAFLD in African countries in relation to prevalence and risk factors. Therefore, the aim of this study is to determine the prevalence of NAFLD and risk factors among asymptomatic co-patients accompanying patients admitted to gastroenterology wards at the National Centre for GI & Liver Diseases, Ibn Sina Hospital (Khartoum, Sudan). PATIENTS AND METHODS: Subjects with liver disease, excess alcohol intake (the intake of more than 21 units of alcohol per week for men and 14 units for women per week) and pregnancy were excluded from this study. The age, sex, body mass index (BMI), history and duration of diabetes and hypertension were recorded. Ultrasound was offered followed by clinical examination and blood sample was taken for assessment of liver function from each subject (total number of participants was 100).
RESULTS: NAFLD was diagnosed in 20 patients, giving prevalence of 20%. There was no statistical significance between the two sexes. The mean age of subjects with NAFLD was 53 years old and without NAFLD was 40 years (p<0.05). Importantly, the prevalence of NAFLD increased with age and BMI. Due to small number of diabetic individuals and hypertension, these two conditions were not statistically significant when related to NAFLD.
CONCLUSION: The estimated prevalence of NAFLD in our study is 20% and this figure is comparable to the prevalence of NAFLD in Asian countries. Males and females were nearly equally affected and the prevalence of NAFLD increased with age and BMI, making obesity a main risk factor.
Copyright © 2014 Arab Journal of Gastroenterology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diabetes; NAFLD; Obesity; Prevalence; Sudanese

Mesh:

Substances:

Year:  2014        PMID: 24630507     DOI: 10.1016/j.ajg.2014.01.008

Source DB:  PubMed          Journal:  Arab J Gastroenterol        ISSN: 1687-1979            Impact factor:   2.076


  10 in total

Review 1.  Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.

Authors:  Zobair Younossi; Quentin M Anstee; Milena Marietti; Timothy Hardy; Linda Henry; Mohammed Eslam; Jacob George; Elisabetta Bugianesi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

2.  Protective Effect of Meretrix meretrix Oligopeptides on High-Fat-Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.

Authors:  Fangfang Huang; Jiajia Wang; Fangmiao Yu; Yunping Tang; Guofang Ding; Zuisu Yang; Yu Sun
Journal:  Mar Drugs       Date:  2018-01-23       Impact factor: 5.118

3.  Non-alcoholic fatty liver disease in Africa: a hidden danger.

Authors:  Imran M Paruk; Fraser J Pirie; Ayesha A Motala
Journal:  Glob Health Epidemiol Genom       Date:  2019-04-12

4.  Prevalence and risk factors of sonographically detected non alcoholic fatty liver disease in a screening centre in Klang Valley, Malaysia: an observational cross-sectional study.

Authors:  Abdul Sattar Arif Khammas; Hasyma Abu Hassan; Sarah Qahtan M Salih; Hayati Kadir; Ramlah Mohamad Ibrahim; Nurul Nadiah Mohamad Nasir; Rozi Mahmud
Journal:  Porto Biomed J       Date:  2018-09-19

Review 5.  Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease.

Authors:  Huapeng Lin; Xinrong Zhang; Guanlin Li; Grace Lai-Hung Wong; Vincent Wai-Sun Wong
Journal:  J Clin Transl Hepatol       Date:  2021-08-30

6.  Prevalence and Risk Factors for Acute Coronary Syndrome Among Sudanese Individuals With Diabetes: A Population-Based Study.

Authors:  Mohamed H Ahmed; Heitham Awadalla; Wadie M Elmadhoun; Mugtaba Osman; Sufian K Noor; Ahmed O Almobarak
Journal:  Cardiol Res       Date:  2017-10-27

Review 7.  Non-Alcoholic Fatty Liver Disease in Africa and Middle East: An Attempt to Predict the Present and Future Implications on the Healthcare System.

Authors:  Mohamed H Ahmed; Sufian K Noor; Sarra O Bushara; Nazik Elmalaika Husain; Wadie M Elmadhoun; Ibrahim A Ginawi; Meissa M Osman; Abdalhafeez O Mahmoud; Ahmed O Almobarak
Journal:  Gastroenterology Res       Date:  2017-10-26

8.  The role of anthropometric indices in the prediction of non-alcoholic fatty liver disease in the PERSIAN Guilan Cohort study (PGCS).

Authors:  Roya Mansour-Ghanaei; Fariborz Mansour-Ghanaei; Mohammadreza Naghipour; Farahnaz Joukar; Zahra Atrkar-Roushan; Mohammadjavad Tabatabaii; Najmeh Ghorani
Journal:  J Med Life       Date:  2018 Jul-Sep

9.  Proteomics approach to investigate dynamic protein profile involved in high fat diet-induced fatty liver disease in rats.

Authors:  Baohua Huang; Yanling Yao; Yaping Li; Hua Yang; Huchen Liu; Heng Liu; Dongming Li; Wei Shu; Ming Chen
Journal:  J Toxicol Pathol       Date:  2019-03-19       Impact factor: 1.628

10.  Liver function tests and fibrosis scores in a rural population in Africa: a cross-sectional study to estimate the burden of disease and associated risk factors.

Authors:  Geraldine O'Hara; Jolynne Mokaya; Philippa C Matthews; Robert Newton; Jeffrey P Hau; Louise O Downs; Anna L McNaughton; Alex Karabarinde; Gershim Asiki; Janet Seeley
Journal:  BMJ Open       Date:  2020-03-31       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.